Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shinsuke Ohta
ERK1/2 Associates With the C-Met-Binding Domain of Growth Factor Receptor-Bound Protein 2 (Grb2)-Associated Binder-1 (Gab1)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Inhibition of Tumor Metastasis by a Growth Factor Receptor Bound Protein 2 SRC Homology 2 Domain-Binding Antagonist
Cancer Research
Cancer Research
Oncology
SRC Phosphorylates Grb2-Associated Binder 1 Upon Hepatocyte Growth Factor Stimulation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Differential Interactions of the Growth Factor Receptor-Bound Protein 2 N-Sh3 Domain With Son of Sevenless and Dynamin
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Kinase Insert Domain Receptor/Vascular Endothelial Growth Factor Receptor 2 (KDR) Genetic Variation Is Associated With Ovarian Hyperstimulation Syndrome
Reproductive Biology and Endocrinology
Gynecology
Endocrinology
Reproductive Medicine
Developmental Biology
Obstetrics
The N-Terminal Domain of Hepatocyte Growth Factor Inhibits the Angiogenic Behavior of Endothelial Cells Independently From Binding to the C-Met Receptor
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Identification of an Atypical Grb2 Carboxyl-Terminal SH3 Domain Binding Site in Gab Docking Proteins Reveals Grb2-Dependent and -Independent Recruitment of Gab1 to Receptor Tyrosine Kinases
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Insulin-Like Growth Factor 2 Binding Protein 2 Gene Polymorphism in Egyptian Patients With Type 2 Diabetes
The Egyptian Journal of Biochemistry and Molecular Biology
Aldehyde Dehydrogenase (ALDH); C-Met Proto-Oncogene (MET; HGFR); Epidermal Growth Factor Receptor 1 (EGFR1; HER1; ErbB1)
Science-Business eXchange
Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes
